Search for: "Schering AG"
Results 21 - 40
of 89
Sorted by Relevance
|
Sort by Date
30 Sep 2010, 8:19 am
" Bayer Schering Pharma AG et al v. [read post]
1 May 2009, 8:25 am
SEC Investigating Schering-Plough Trades: The SEC is investigating trading of Schering-Plough shares ahead of the announcement of its merger with Merck & Co., people familiar with the matter said. [read post]
7 Sep 2008, 2:47 pm
For example, let's look at Schering-Plough's "49 Plan," which was an aggressive seven-week sales push to increase Zetia prescriptions across the country. [read post]
22 Aug 2014, 6:20 am
Methods: We conducted a case-control study within a cohort of men aged 45 to 80 years in the United States followed from 2001 to 2011. [read post]
FTC and California AG Join in Challenging Reverse Payment Settlements in the Pharmaceutical Industry
6 Mar 2009, 7:03 am
Schering-Plough Corp. v. [read post]
6 Mar 2008, 9:53 pm
By Kevin E. [read post]
22 Apr 2010, 3:51 am
Teva (Orange Book Blog) (FDA Law Blog) Levistra (Vardenafil) – US: District Court Delaware: Patent infringement complaint following ANDA filing: Bayer Schering Pharma AG et al v Teva Pharmaceuticals USA, Inc et al (Patent Docs) Nexavar (Sorafenib) – India: Bayer sues Cipla for infringement of Nexavar patent before Delhi High Court (Spicy IP) Norfloxacin – Canada: Federal Court: Judgment in s 8 proceeding: Apotex v Merck (Pharmacapsules) Prandin (Repaglinide)… [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Levitra (Vardenafil) – US: Patent infringement complaint following a Paragraph IV certification: Bayer Schering Pharma AG et al. v. [read post]
28 Sep 2009, 1:08 am
The study was funded with an unrestricted grant from Bayer Schering Pharma AG. [read post]
14 Mar 2009, 5:13 am
This study was funded by Schering-Plough. [read post]
25 Oct 2011, 9:28 am
The FTC also lost a case in the 11th Circuit challenging a pay for delay deal between Schering-Plough Corp., Upsher-Smith Laboratories and American Home Products Corp. involving the high blood pressure medication K-Dur 20. [read post]
23 Jun 2010, 10:28 pm
(Patent Docs) Viagra (Sildenafil) - Brazil: Snag in early end to Viagra patent in Brazil (IP Watch) Yaz (Drospirenone and ethinyl estradiol) - US: Patent infringement and false advertising complaint based on generic Yaz product, Gianvi: Bayer Schering Pharma AG et al. v. [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
24 Nov 2009, 2:41 pm
We look forward to eventually seeing the results obtained from this INAS-OC Study, which is reportedly funded by an unconditional grant from Bayer Schering Pharma AG, Berlin. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects [read post]
22 Nov 2011, 5:42 am
., acquired in the 2006 purchase of Schering AG, received an e-mail that year from a company official citing a Woman’s Day magazine article about Yaz.From the email: “This article is a nice way of using YAZ for PMS treatment instead of just focusing on the specific” class of women battling premenstrual dysphoric disorder, the most severe form of PMS, wrote Matt Sample, a Berlex sales consultant, according to a copy of the e-mail produced as evidence. [read post]
19 Jan 2010, 12:00 am
Recently Schering Corp. [read post]
29 Nov 2007, 2:29 pm
FDA staffers said no date for the meeting has been set.Those "other" asthma drugs to be consider at this future FDA meeting would be GSK's Advair and Foradil, made by Novartis AG (NVS) and sold in the U.S. by Schering-Plough Corp.As for the suggestion that Serevent and Advair should be recalled from the market, this idea was rejected by an FDA official and a GSK representative. [read post]
23 May 2011, 1:54 pm
Court of Appeals for the Eleventh Circuit upheld in Schering-Plough Corp. v. [read post]
11 Sep 2009, 3:00 pm
Prior to Secretary Wells' appointment, she was President of the Schering-Plough Foundation, the philanthropic arm of the Schering Plough Corporation and the Vice-President of Public Affairs at Schering-Plough Corporation. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/25: Schering-Plough Healthcare Products, Inc. v. [read post]
